HONG KONG, Sept. 6, 2011 /PRNewswire-Asia-FirstCall/ --
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),
China's leading provider of cord
blood collection, laboratory testing, hematopoietic stem cell
processing, and stem cell storage services, today announced that
the Company will participate in the following investor
conferences:
- The Morgan Stanley Global Healthcare Conference, to be held
September 13-14, 2011 at the Grand
Hyatt New York, and the Morgan Stanley China Healthcare Day, to be
held September 15, 2011 at the Four
Seasons Hotel in Boston.
Management is scheduled to present and to meet with institutional
investors throughout both days of both conferences.
- The UBS Global Life Sciences Conference, to be held
September 19-21, 2011 at the Grand
Hyatt New York. Management is scheduled to present and to meet with
institutional investors throughout the first two days of the
conference.
For further details, please contact your respective
institutional sales representatives.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest cord blood
banking operator in China in terms
of geographical coverage and is the only cord blood banking
operator with multiple licenses. Under current PRC government
regulations, only one licensed cord blood banking operator is
permitted to operate in each licensed region and only seven
licenses have been authorized as of today. China Cord Blood
Corporation provides cord blood collection, laboratory testing,
hematopoietic stem cell processing and stem cell storage services.
For more information, please visit our website at
http://www.chinacordbloodcorp.com.
For more information, please
contact:
|
|
|
|
China Cord Blood
Corporation
|
|
Ms. Joeling Law
|
|
Tel: +852-3605-8180
|
|
Email: ir@chinacordbloodcorp.com
|
|
|
|
ICR, Inc.
|
|
In New York: Ashley Ammon De
Simone: +1-646-277-1227
|
|
In Beijing: Wen Lei Zheng:
+86-10-6583-7510
|
|
|
SOURCE China Cord Blood Corporation